Over 180.3 million PCR checks have been performed within the nation to this point
The UAE Ministry of Well being and Prevention on Tuesday reported 775 instances of the Covid-19 coronavirus, together with 656 recoveries and no deaths.
Whole energetic instances stand at 19,181.
The brand new instances have been detected by 197,168 further checks.
The overall variety of instances in UAE as on August 16 are 1,006,318, whereas whole recoveries stand at 984,798. The loss of life toll now stands at 2,339.
Pfizer Inc Chief Govt Officer Albert Bourla mentioned on Monday he had examined optimistic for Covid-19 and was experiencing very delicate signs.
Bourla, 60, mentioned he had began a course of the corporate’s oral Covid-19 antiviral remedy, Paxlovid, and was isolating and following all public well being precautions.
“I’m assured that I’ll have a speedy restoration,” Bourla mentioned in an announcement.
A number of public figures have examined optimistic for the infectious illness previously few months together with US President Joe Biden and his chief medical adviser, Dr Anthony Fauci.
Biden spent greater than two weeks remoted within the White Home after two bouts with Covid-19, the second occasion is believed to be a “rebound” skilled by some Covid sufferers who take Paxlovid.
Paxlovid is an antiviral treatment that’s used to deal with high-risk folks, resembling older sufferers.
Bourla has acquired 4 doses of the Covid vaccine developed by Pfizer and its German associate BioNTech.
In the meantime, the Serum Institute of India is predicted to create a brand new Omicron-specific vaccine inside six months.
In accordance with NDTV, institute chief Adar Poonawalla says the pharma big is already working with US biotech firm Novavax to develop a vaccine in opposition to Omicron sub-variant BA-52.
“Suppose this vaccine is essential as a booster,” mentioned Poonawalla, including that Omicron is “not delicate” and infrequently manifests like a “severe flu.”
Nevertheless, the vaccine can solely enter the market as soon as authorized by nationwide regulators; it isn’t clear whether or not a separate Indian medical trial is required.
“Trials of Novavax are in progress in Australia at the moment. By November-December must be ready to method the US drug regulator,” Mr Poonawalla mentioned.